0.829
IF
20
MNiSW
166.26
ICV
RESEARCH PAPER
 
CC BY-NC-ND 3.0
 
 

Impact of selected environmental factors on attendance in the Breast and Cervical Cancer Early Detection Programme in the Wielkopolska Province of Poland during 2007–2012

Witold Kycler 1  ,  
Anna Kubiak 2,  
 
1
Department of Oncological Surgery, Greater Poland Cancer Centre, Poznan, Poland, Department of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland
2
Greater Poland Cancer Registry, Greater Poland Cancer Centre, Poznań, Poland
3
Department of Mother’s and Child’s Health, University of Medical Sciences, Poznań, Poland
4
Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poland
5
Department of Informatics and Health Statistics, Institute of Rural Health, Lublin, Poland
6
Faculty of Pedagogy and Psychology, University of Economics and Innovation, Lublin, Poland
7
Department of Social Sciences, University of Medical Sciences, Poznań, Poland
Ann Agric Environ Med 2017;24(3):467–471
KEYWORDS:
ABSTRACT:
Breast and cervical cancer represent a significant health and economic issue for Polish society, although if detected early, both can be cured successfully. For this reason, since 2006, according to the National Cancer Combat Programme, population-based screening programmes have been implemented, aimed at reducing the mortality and morbidity for breast and cervical cancer. The aim of this study is to determine which of the selected four environmental factors affect attendance for screening mammography and cytology. Analysis included data from questionnaires filled in during mammography by 582,959 women aged 50–69 years, and 288,142 women during cytology, aged 25–59 years, in 2007–2012 in the Wielkopolska Province of Poland. It was found that the impact of medical staff on the attendance for cytological screening was the strongest statistically significant factor (p = 0,0001). Invitation by name (p=0,001) and other factors (p= 0,0001) also affected the attendance. In the cytological screening, medical staff was the factor that had the greatest impact on attendance. Other factors, such as self-reporting, increased participation in the next screening rounds, although the factors that affect attendance changed over time. Their constant analysis is essential for the efficient and effective evaluation of screening programsme.
CORRESPONDING AUTHOR:
Witold Kycler   
Department of Oncological Surgery, Greater Poland Cancer Centre, Poznan, Poland, Department of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland
 
REFERENCES (27):
1. Boyle P. Lewin B. World Cancer Report. Lyon International Agency for Research on Cancer. 2008.
2. Verdecchia A. Francisci S. Brenner H. Gatta G. Micheli A. Mangone L et al. Recent: cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007; 8(9): 784–96.
3. Globocan database 2008 (http://globocan.iarc.fr/) (access: 2013.02.05).
4. Petra T. Breast cancer in the elderly—Should it be treated differently? Rep Pract Oncol Radiother. 2013; 18(1): 1–5.
5. Waller J. Bartoszek M. Marlow L. Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2009; 16(4): 199–204.
6. Kazmierska J. Assessment of health status in elderly patients with cancer. Rep Pract Oncol Radiother. 2013; (18): 44–48.
7. Otto SJ. Fracheboud J. Verbeek AL. Boer R. Reijerink-Verheij JC. Otten JD et al. Mammography Screening and Risk of Breast cancer Death: A Population-based Case –Control study cancer. Epidemiol Biomarkers Prev. 2012; 21(1): 66–73.
8. Dyzmann-Sroka A. Myślińska W. Olenderczyk W. Plucińska A. Rymarczyk-Wciorko M. Szczęch B et al. Nowotwory złośliwe w Wielkopolsce w 2010 roku. Poznań Wielkopolskie Centrum Onkologii 2012.
9. Krajowy Rejestr Nowotworów http://85.128.14.124/krn/ (access 2013.02.05).
10. Pieta B. Chmaj-Wierzchowska K. Opala T. Life style and risk of development of Brest and ovarian cancer. Ann Agric Environ Med. 2012; 19(3): 379–384.
  WWW
11. Ustawa z dnia 1 lipca 2005 r. o ustanowieniu programu wieloletniego Narodowy program zwalczania chorób nowotworowych. Dz. U. 08.54.325.
12. Zarządzenie nr 11/2010/ DSOZ Prezesa NFZ z dnia 29 stycznia 2010.
13. Giordano L. von Karsa L. Tomatis M. Majek O. de Wolf C. Lancucki L et al. Mammography screening programmes In Europe: organization. coverage and participation. J Med Screen. 2012. 19(1); 72–82.
14. Tacken MA. Braspenning JC. Hermens RP. Spreeuwenberg PM. van den Hoogen HJ. de Bakker DH et al. Uptake of cervical cancer screening in The Netherlands is mainly influenced by women’s beliefs about the screening and by the inviting organization. Eur J Publ Health. 2007; 17(2): 178–185.
15. Giordano L. von Karsa L. Tomatis M. Majek O. Wolf Ch. Lancucki L et al. Mammography screening programmes in Europe: organization. coverage and participation. J Med Screen. 2012; 19(1): 72–82.
16. Rossi PG. Camillowi L. Cogo C. Federici A. Furnari G. Giordano L et al. Methods to increase participation in cancer screening programmes. Epidemol Prev. 2012; 36(1): 1–104.
17. Matkowski R. Szynglarewicz B. First report of introducing population-based breast cancer screening in Poland: Experience of the 3-million population region of Lower Silesia. Cancer Epidemiology. 2011; 35 (6): 111–115.
18. Perry N. Broeders M. de Wolf C. Törnberg S. Holland R. Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg Office for Official Publications of the European Communities. 2006.
19. Arbyn A, Anttila J, Jordan G, Ronco U, Schenck N, Segnan H et al. European guidelines for quality assurance in cervical cancer screening Second Edition 2008. 2nd ed. Luxembourg Office for Official Publications of the European Communities. 2008.
20. OECD Health Data 2012; Eurostat Statistics Database.
21. Bojar I. Cvejić R. Głowacka M. Koprowicz A. Humeniuk E. Owoc A. Morbidity and mortality due to cervical cancer in Poland after introduction of the Act – National Programme for Control of Cancerous Diseases. Ann Agric Environ Med. 2012; 19(4): 680–685.
22. Krzyzak M. Maslach D. Juczewska M. Lasota W. Rabczenko D. Marcinkowski J. et al. Differences in breast cancer incidence and stage distribution between urban and rural female population in Podlaskie Voivodship. Poland in years 2001–2002. Ann Agric Environ Med. 2010; 17(1): 159–162.
23. Banks E. Richardson A. Beral V. Crossley B. Simmonds M. Hilton E et al. Effect on attendance at Brest cancer screening of adding a self administered questionnaire to the usual invitation to Brest screening In southern England. J Epidemiol Community Health. 1998; 52(2): 116–119.
24. Antilla A. Ronco G. Working Group on the Registration and monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer. 2009; 45(15): 2685–2708.
25. Spaczyński M. Karowicz-Bilińska A. Rokita W. Molińska-Glura M. Januszek-Michalecka L. Seroczyński P et al. Attendance rate in the polish cervical cancer screening program In the year 2007–2009. Ginekol Pol. 2010; 81(9): 655–663.
26. Spaczyński M. Nowak-Markwitz E. Januszek-Michalecka L. Karowicz-Bilińska A. Women’s social conditions and their participation In Cervical cancer population screening program in Poland. Ginekol Pol. 2009; 80(11): 833–838.
27. Owoc A. Cveic R. Koprowicz A. Sygit K. Frontczak A. Bojar I. Reporting rates for cervical screening in the Szczecin Region during the period 2007–2010 Ann Agric Environ Med 2012; 19: 4.686–91.
eISSN:1898-2263
ISSN:1232-1966